Implementing well‐being in the management of psoriasis: An expert recommendation

• Published in: Journal of the European Academy of Dermatology and Venereology 2024-02, Vol.38 (2), p.302-310
• Main Authors: Sommer, Rachel, Mrowietz, Ulrich, Gaarn Du Jardin, Kristian, Kasujee, Ismail, Martini, Elisa, Daudén, Esteban, Fabbrocini, Gabriella, Zink, Alexander, Griffiths, Christopher E. M., Augustin, Matthias
• Format: Article
• Language: English
• Subjects: Delivery of Health Care; Humans; Psoriasis - psychology; Psoriasis - therapy; Quality of Life; Skin
• ISSN: 0926-9959; 1468-3083
• DOI: 10.1111/jdv.19567

Psoriasis causes detriment in a person's physical, mental and social health which impairs their quality of life (QoL). However, the current psoriasis management may not adequately address all relevant health domains. Since the goal of healthcare is to restore or maintain health, health outcomes should include all areas of the patient's overall health. Life satisfaction, QoL and patient well‐being are essential to a comprehensive approach to the disease. With the inclusion of more people‐centred policies, care of patients with psoriasis should evolve towards a holistic and integrated assessment of the disease impact, including subjective measures of well‐being in order to encompass all aspects of health. The main objective of this expert review is to give the concept of well‐being a place as an entity within the holistic therapeutic approach for patients with psoriasis. Identifying and defining common goals beyond the skin with the patient and testing them throughout the course of treatment will benefit and enhance treatment success. We propose a series of recommendations for application in clinical practice, providing tangible clinical guidance for implementing well‐being in the management of psoriasis. Among the recommendations are the need to initially listen to the patient, to know their level of empowerment or what they want to achieve, their preferences in decision making, the evaluation of not only the physical but also the emotional impact of the disease (well‐being), the definition of the aspects that can generate a cumulative deterioration of the disease throughout life, and a continuous assessment of the patient's preferences with the opinion of the expert clinician and the integration of the knowledge of external clinical evidence.